Opsins form a family of light-activated, retinal-dependent G-protein coupled receptors (GPCRs) that serve a multitude of visual and non-visual functions. Opsin3 (OPN3 or encephalopsin), initially identified in the brain, remains one of the few members of the mammalian opsin family with unknown function and ambiguous light-absorption properties. We recently discovered that OPN3 is highly expressed in human epidermal melanocytes-the skin cells that produce melanin. The melanin pigment is a critical defense against ultraviolet radiation and its production is mediated by the Gs-coupled melanocortin-1 receptor (MC1R). The physiological function and light-sensitivity of OPN3 in melanocytes is yet to be determined.
Introduction
Unlike most mammals which have melanin-producing melanocytes predominantly in the hair follicle bulb [1] , humans are uniquely equipped with melanocytes in the outermost layer of the skin, the epidermis [2, 3] . These neural crest-derived melanocytes are the only source of the photoprotective pigment melanin in human skin and, thus, are critical for the defense against solar ultraviolet radiation (UVR)-induced genotoxic damage [4] [5] [6] .
Solar UVR at the surface of the earth is comprised of ~5% short-wavelength UVB and ~95% longwavelength UVA. Much of our current knowledge about melanogenesis in epidermal melanocytes stems from the well-characterized UVB-induced melanin pathway [7] . UVB elicits DNA damage in epidermal keratinocytes, triggering facultative skin darkening through increased melanin production in neighboring melanocytes [8] . UVB irradiated keratinocytes and melanocytes locally secrete alpha-melanocyte stimulating hormone (αMSH), an agonist of the Gαs-coupled melanocortin-1 receptor (MC1R) that is primarily expressed on melanocytes [8, 9] . MC1R has a pivotal role in determining pigmentation, as several naturally occurring loss-of-function MC1R variants are associated with the "red hair phenotype" [10, 11] characterized by pale complexion and increased sensitivity to UVR [12] . Downstream, αMSHinduced MC1R activation leads to stimulation of adenylyl cyclase (AC) and production of cyclic adenosine monophosphate (cAMP). Accumulation of cAMP, through several molecular steps, induces upregulation of microphthalmia transcription factor (MITF)-the master transcription factor leading to increased expression of melanogenic enzymes like tyrosinase (TYR) [13] .
In addition to the UVB pathway, we recently characterized a novel UVA-induced melanogenic pathway in human epidermal melanocytes (HEMs). This retinal-dependent phototransduction pathway is mediated by Gαq/11 activation, resulting in a rapid increase in intracellular Ca 2+ and elevated cellular melanin levels [14] [15] [16] . The identity of the putative GPCR that mediates the UVA phototransduction cascade remains unknown, but members of the retinal-dependent, light-sensitive opsin family are ideal candidates. Coincidentally, in HEMs, we and others have found expression of mRNA corresponding to several opsins [16] [17] [18] [19] [20] ; opsin3 (OPN3), which has unknown physiological function, has significantly higher mRNA expression than any other detected opsin [18] .
The scarcity of functional data on OPN3, discovered nearly 20 years ago [21, 22] , may derive from its unique structure and widespread expression ranging from deep brain regions [21, 22] to peripheral tissues [23] . OPN3 has a unique, long carboxy (C)-terminus with no sequence homology to any known GPCR. Recent studies have determined the photoreceptive properties for several OPN3 homologs [24] [25] [26] : zebrafish, pufferfish, and chicken OPN3 absorb blue light (λmax=465 nm) [25] ; mosquito OPN3 forms a bistable photopigment with 13-cis, 11-cis and 9-cis retinal, absorbs blue-green light (λmax=490 nm), and activates G-proteins Gi/o in a light-dependent manner [24, 26] . However, the light sensitivity, G-protein coupling, and function of human OPN3 remain unknown.
Here we show that OPN3 is a negative regulator of melanogenesis in human melanocytes. OPN3 does not mediate the UVA-evoked Ca 2+ -response of HEMs, nor does it modulate the sensitivity of these cells to visible light, despite being able to bind 11-cis and all-trans retinal. OPN3 couples to Gαi to negatively regulate the αMSH-induced cAMP response of MC1R. In addition, OPN3 and MC1R form a physical complex. Our data identify a novel melanogenic regulatory mechanism and a key function of human OPN3 in skin, both of which expand our knowledge of melanocyte physiology.
Results
OPN3 does not mediate Ca 2+ -dependent UVR phototransduction in HEMs. Physiological doses of UVR induce a retinal-and PLC-dependent transient increase in cytosolic Ca 2+ , mediated by activation of Gq/11 via an unknown putative GPCR [14] [15] [16] . Because mosquito OPN3 activates Gi/o subunits of G-proteins in a light-dependent manner [24] and the Gγ subunits that dissociate from Gi are able to activate PLC and cause a Ca +2 response, we reasoned that OPN3 may be the GPCR that mediates UVR phototransduction in HEMs. Like all opsins, OPN3 possesses a lysine in the seventh transmembrane domain (K299) and a negatively-charged counterion in the third transmembrane domain (D117) (Fig. 1A) , both involved in the binding of retinal chromophore to the opsin apoprotein [27] , thus conferring light sensitivity.
To determine if OPN3 mediates UVR phototransduction, we reduced OPN3 levels in HEMs using two OPN3-targetted miRNAs (OPN3-1 and OPN3-2). Each miRNA reduced the level of OPN3 mRNA by more than 60% compared to control scrambled miRNA (CTRL) ( Fig. 1B) . To confirm that OPN3 protein levels were also reduced, we first validated an antibody against the unique C-terminus of OPN3 (Fig.   1C ). Using this antibody, we showed that OPN3 protein levels are also reduced by more than 60% in HEMs expressing OPN3-1 or OPN3-2 miRNA ( Fig. 1D) . We monitored intracellular Ca 2+ levels using the fluorometric Ca 2+ indicator Fluo-4 AM in HEMs preincubated with all-trans retinal and expressing OPN3- This idea is plausible given that OPN3 homologues are sensitive to blue-green light [24] . We monitored the Ca 2+ responses of HEMs expressing CTRL or OPN3-targeted miRNAs, pre-incubated with all-trans retinal, and exposed to 200 mJ/cm 2 of blue (max=450 nm) or green (max=550 nm) light. HEMs expressing CTRL miRNA did not have a significant Ca 2+ response to blue or green light, and neither did HEMs expressing OPN3-targetted miRNAs (Figs. 1E and 1F, middle and right panels).
Because the miRNAs partially reduced OPN3 expression and the residual OPN3 could be sufficient for the UVR response, we used CRISPR/Cas9 to eliminate OPN3. Primary HEMs with CRISPR/Cas9induced mutations did not survive the selection of clonal lines; we used immortalized human epidermal melanocytes (Hermes 2b), which express similar levels of MC1R and OPN3 mRNA as HEMs (Supp. Fig.   1A ) to generate clonal CRISPR/Cas9 lines. Hermes 2b cells containing a mutation introduced in exon1 of OPN3 lack OPN3 expression (Supp. Fig. 1B These findings raised an interesting question: does human OPN3 form a photopigment? Spectroscopic analyses of recombinant OPN3 homologues indicated that they can bind 11-cis retinal and have an absorption maximum at ~470 nm [24, 25] . To determine if human OPN3 and retinal form a photopigment, we expressed C-terminal truncated, 1D4-tagged human OPN3 (OPN3ΔC-c1D4) [28] in HEK293 GnTIcells. We also expressed a variant in which the retinal-binding residue K299 was mutated to glycine [OPN3(K299G)ΔC-c1D4] ( Fig. 2A, right) , a mutation shown to abolish retinal-binding and light sensitivity of rhodopsin and other opsins [29, 30] . Neither the OPN3 C-terminal truncation nor the K299G mutation affected the cellular localization of OPN3 in a heterologous system as compared to C-terminal-tagged, full-length OPN3-MCherry (OPN3-cMCh) ( Fig. 2B; Fig. 2A , left). UV-visible spectroscopy using purified OPN3ΔC-c1D4 protein or the K299G mutant protein revealed a significant protein peak for both proteins, but no detectable absorption peak at max>300 nm for either ( Fig. 2C) . To test if retinal was bound to human OPN3, we treated the purified proteins with a mixture of hydroxylamine (NH2OH) and sodium dodecyl sulfate (SDS) (Fig. 2C, insets) . When retinal is bound to the apoprotein, SDS denatures the protein to expose the Schiff base that reacts with NH2OH to release retinal oxime, which absorbs at max=360 nm [31, 32] . Upon treatment with NH2OH and SDS, a retinal oxime absorption peak was observed for OPN3ΔC-c1D4 treated with both 11-cis retinal (Fig. 2C , left) or all-trans retinal (Supp. Fig.   2A ) but not for OPN3(K299G)ΔC-c1D4 ( Fig. 2C, right) . This data suggests that OPN3, unlike the K299G mutant, can bind 11-cis retinal and all-trans retinal. Moreover, the reduced amplitude of the retinal oxime peak compared to the protein peak (λmax =280 nm) and purity of protein samples (Supp. Fig. 2C ) suggest that OPN3 binds retinal in a weak manner.
OPN3 is a negative regulator of melanin levels in human melanocytes. We observed that HEMs with reduced OPN3 expression (OPN3-1 and OPN3-2 miRNAs) appeared more pigmented than CTRL miRNA-expressing HEMs (Fig 3A, left insets). Quantification of cellular melanin revealed that HEMs with reduced OPN3 had significantly higher melanin levels than control (Fig 3A, left graph). Similar to miRNAtreated HEMs, Hermes 2b cells lacking OPN3 have significantly higher melanin levels than control cells (Supp. Fig. 1C ). We then tested the reciprocal: do elevated OPN3 levels lead to reduced melanin?
Because we were not able to efficiently express exogenous OPN3 in HEMs, we used the pigmented melanoma cell line MNT-1. MNT-1 cells are highly pigmented and have been used extensively as a model system for melanocyte function because they preserve most primary melanocyte signaling and trafficking pathways. MNT-1 cells have MC1R levels comparable to HEMs, but lower OPN3 mRNA levels ( Fig. 3B) . We transfected MNT-1 cells with OPN3-cMCh or with only MCherry (MCh) and quantified cellular melanin levels. MNT-1 cells expressing OPN3-cMCh have an approximate 60% reduction in melanin levels as compared to MNT-1 expressing MCh (Fig. 3A, right graph) . These results indicate that OPN3 negatively modulates the melanin levels of human melanocytes. Because Hermes 2b cells have lower levels of MC1R (Supp. Fig. 1A) , we used the more sensitive cAMP indicator R-FlincA instead of Epac H187. Hermes 2b cells expressing YFP (CTRL YFP) exhibit a significant MSH-induced cAMP response, while expression of OPN3-cYFP leads to a negligible cAMP response under similar conditions. These results confirm that OPN3 negatively modulates MSHinduced MC1R cAMP signaling ( Fig. 4Ci yellow v. light green traces and 4Cii).
To determine whether OPN3 modulation is specific to MC1R-mediated cAMP signaling, we stimulated the endogenous Gs-coupled prostaglandin EP2 receptor in MNT-1 cells expressing MCh or OPN3-cMCh. Stimulation of the EP2 receptor with prostaglandin led to a ~60% increase in cAMP both in MNT-1 cells expressing OPN3-cMCh and those expressing MCh ( Figs. 4Aii and 4Aiv ). This suggests that OPN3 does not modulate all Gs-coupled receptors, but specifically regulates MC1R-mediated cAMP signaling.
We next determined how OPN3 negatively regulates MC1R signaling. Gs signaling can be inhibited by the act of a Gi-coupled GPCR [35] . To test if OPN3 couples to Gi to reduce MC1R-mediated cAMP accumulation, we treated MNT-1 cells expressing MCh or OPN3-cMCh with Pertussis toxin (PTX), an inhibitor of Gi signaling [8] . PTX-treated MNT-1 cells expressing MCh had a robust cAMP response to MSH, as expected. PTX-treated MNT-1 expressing OPN3-cMCh had a similarly robust response to MSH, unlike the negative regulatory affect OPN3 displays without PTX (Figs. 4Aiii compared to 4Ai and 4Aiv). PTX-mediated inhibition of Gi signaling abolishes the negative regulation OPN3 has on MC1R cAMP signaling and suggests that OPN3 couples to Gi. Interestingly, the lysine mutation of OPN3(K299G) did not affect the OPN3-mediated negative modulation of MC1R signaling ( Figs. 4Bi and   4Biii ) and PTX abolished the effect of OPN3(K299G) in MNT-1 and Hermes 2b ( Figs. 4Bii, 4Biii, 4Ci,   4Cii ). This indicates that OPN3 has a regulatory influence over MC1R despite its ability to bind retinal.
After MC1R-mediated cAMP levels increase, several molecular steps, including increased expression of MITF and upregulation of TYR, lead to an increase in melanin levels [36] . If OPN3 negatively regulates this pathway, as our cAMP data suggests, reducing OPN3 expression should increase MC1R-mediated signaling, increasing MITF and TYR expression. Indeed, HEMs expressing OPN3-2 miRNA (the more efficient of the two OPN3-targeted miRNAs) have higher levels of MITF and TYR when compared to HEMs expressing CTRL miRNA ( Fig. 5A) . Conversely, MNT-1 cells expressing OPN3-cMCh had reduced levels of both MITF and TYR, as compared to MNT-1 cells expressing MCh (Fig. 5B) . These results indicate that OPN3 is a negative regulator of MC1R-meditated melanogenic signaling in human melanocytes.
MC1R and OPN3 form a complex. Because OPN3 specifically modulates the signaling of MC1R, we proposed that OPN3 and MC1R could form a molecular complex. This would explain why OPN3 and not EP2 modulates MC1R cAMP signaling despite OPN3 and EP2 both being Gi-coupled: OPN3, MC1R and EP2 are all expressed on the plasma membrane, but MC1R and OPN3 could be localized within the same microdomains.
Several recent reports indicate that GPCRs can form functional and physical interactions [37, 38] .
Members of the opsin family, in particular, have been recently shown to form hetero-and homomeric complexes [39, 40] . To determine whether OPN3 and MC1R colocalize to the same cellular compartments, we expressed tagged OPN3 and MC1R in HeLa cells. OPN3-cYFP localized to the plasma membrane, as well as intracellular structures that have partial overlap with the Rab11 marker for recycling endosomes (Supp. Fig. 4 ). To determine if OPN3 colocalization with MC1R is specific to MC1R, we measured OPN3 colocalization with the EP2 receptor, which is also Gs-coupled. We coexpressed in HeLa cells OPN3-cYFP and either N-terminal HA-tagged MC1R (MC1R-nHA) or N-terminal HA-tagged EP2 receptor (EP2-nHA), immunostained with an anti-HA antibody, and quantified colocalization of YFP and HA. Interestingly, MC1R-nHA and OPN3-cYFP significantly colocalized (>50%) in intracellular structures, while EP2-nHA, localized primarily to the plasma membrane, had <10% overlap with OPN3-cYFP ( Fig. 6A) .
To confirm that endogenous OPN3 and MC1R colocalize in HEMs, we first validated anti-OPN3 and anti-MC1R antibodies. Cells expressing OPN3-cYFP or OPN3-cFLAG had significant (>50%) overlap between the fluorescent signals obtained with anti-OPN3 or with the respective tags (YFP or FLAG) ( Fig.   6B ). Similarly, cells expressing MC1R-nHA had significant (>50%) overlap between the fluorescent signals of anti-MC1R and anti-HA antibodies ( Fig. 6C ), suggesting that both anti-OPN3 and anti-MC1R antibodies are specific. Immunostaining HEMs with these antibodies revealed that endogenous OPN3 and MC1R are present both at the plasma membrane and in intracellular compartments and exhibit significant colocalization ( Fig. 6D) .
We next determined if OPN3 and MC1R form a physical complex. We first tested if expressed OPN3-cFLAG and MC1R-nHA interact in HeLa cells. Immunoprecipitation with an anti-FLAG antibody and immunoblot with an anti-HA antibody revealed a band corresponding to the molecular weight of MC1R-nHA, but only when both receptors were expressed ( Fig. 7A) . Similarly, immunoprecipitation with anti-HA antibody and immunoblot with anti-FLAG antibody revealed a band corresponding to OPN3-cFLAG, but only when both receptors were expressed (Supp. Fig. 5 ). These results suggest that in HeLa cells OPN3-cFLAG and MC1R-nHA form a complex. To confirm that endogenous OPN3 and MC1R also interact in HEMs, we confirmed that the anti-MC1R antibody detects the same bands as the anti-HA antibody in HeLa cells expressing MC1R-nHA ( Fig. 7B, left panel) . When HEM lysate is immunoprecipitated with anti-OPN3 antibody and immunobotted with the anti-MC1R antibody, a band corresponding to the molecular weight of MC1R is detected ( Fig. 7B, right panel) , indicating that OPN3 and MC1R form a complex in melanocytes.
Taken together, our results reveal a novel molecular mechanism by which Gαi-coupled OPN3 negatively regulates the cAMP signal resulting specifically from the αMSH-induced activation of MC1R. In addition to the functional interaction, OPN3 and MC1R also form a physical complex, and colocalize at the plasma membrane and also in intracellular structures. The reduced MC1R-mediated cAMP production in the presence of OPN3 leads to reduced activation of MITF, reduced levels of TYR, which ultimately results in decreased melanin production in melanocytes ( Fig. 8 ).
Discussion
In this study we have determined the cellular function of endogenously expressed OPN3 in human melanocytes. We initially hypothesized that OPN3 functioned as the UVR photoreceptor in the UVR-Ca 2+ melanin signaling pathway previously characterized by our laboratory [14] [15] [16] . Surprisingly, our results disproved this hypothesis: we showed that reducing the mRNA and protein levels of OPN3 in melanocytes ( Figs. 1B-D, Supp. Fig. 1B ) did not alter their Ca 2+ -mediated responses to physiological levels of UVR, blue, or green light in melanocytes did not alter the response to UVR, blue or green light ( Figs. 1E and 1F; Supp. Figs. 1D and 1E) . Moreover, when we tested whether purified human OPN3 can respond to visible light, similar to its homologues [24, 25] , we found no evidence of visible light absorption in the OPN3 UV-VIS spectrum (Fig. 2, Supp. Fig. 2B ), despite weakly binding both 11-cis and all-trans retinal ( Fig. 2C and Supp. Fig. 2A ).
We were puzzled by the finding that human OPN3, despite being able to bind retinal, does not have an absorption peak in the visible range ( Fig. 2C and Supp. Fig. 2A ). This is particularly intriguing considering that OPN3 homologues absorb light in the visible spectrum [24] [25] [26] . In addition, unlike two recent reports suggesting that human OPN3 functions in a blue light-dependent manner in human skin [41, 42] and in rat and human pulmonary vasorelaxation [41, 42] , we did not detect OPN3 sensitivity to blue light by either spectrophotometric analysis or by monitoring Ca 2+ levels in melanocytes. One possible scenario is that OPN3 absorbs light outside the range covered by conventional UV-visible spectroscopy (200-700 nm) or that its absorption overlaps with protein absorption (λmax=280 nm) and is masked by the large protein peak [43] . Alternatively, OPN3 may be light-insensitive and function in a similar manner as retinal G protein-coupled receptor (RGR), an opsin receptor that binds retinal independent of light stimulus. It was shown that RGR, independent of light, accelerates the conversion of retinyl esters to 11cis-retinal by modulating isomerohydrolase activity [44] . Thus, it is conceivable that OPN3 is not lightsensitive and retinal binding serves another purpose in OPN3 folding, trafficking, or signaling. Future studies are needed to characterize human OPN3 photosensitivity and to understand the role of retinal in OPN3 function.
Reducing or eliminating OPN3 expression in melanocytes led to a surprising observation: these melanocytes had a significantly higher melanin content ( Fig. 3A; Supp. Fig. 1C ). Because melanin production in melanocytes is controlled by the Gαs-coupled MC1R which signals via cAMP, we used genetically encoded cAMP indicators to measure the effect of OPN3 on MC1R-mediated signaling. We found that OPN3 inhibits the MC1R-mediated cAMP response in a Gαi-dependent manner ( Fig. 4) ,
indicating that MC1R and OPN3 functionally interact. The functional interaction between OPN3 and MC1R is similar to the mechanism described for the cross-regulation of the G protein-coupled estrogen receptor (GPER) and steroid hormone adipoQ receptor 7 (PAQR7), in which PAQR7 regulates skin pigmentation through Gi-mediated downregulation of GPER activity [45] . The ability of OPN3 to negatively regulate MC1R signaling does not appear to require retinal binding to OPN3, as the OPN3(K299G) mutant is able to modulate MC1R-mediated signaling, despite not binding retinal ( Fig. 4) , further supporting the idea that OPN3 functions in a light-independent manner in melanocytes.
Human OPN3 is likely to be coupled to Gi, similar to its homologues [24] [25] [26] . Indeed, using PTX to prevent Gi activation eliminated the inhibitory effect of OPN3 on MC1R-mediated cAMP signaling ( Figs.   4Aiii and 4Aiv) . These results indicate that OPN3 is coupled to Gi either constitutively or, alternatively, light might turn off OPN3 that is coupled to Gi. In this case, exposure to light would uncouple OPN3 from Gi, resulting in an increase in the baseline cAMP. Initially, we were not able to measure lightinduced OPN3-dependent changes in cAMP in melanocytes, because the FRET indicator Epac H187, used to monitor cAMP, requires illumination of the cells with visible light in the blue-green range (~ 400-530 nm). Thus, if the light used for Epac H187 imaging was sufficient to inactivate OPN3, the increase in cAMP could occur prior to starting image acquisition. We circumvented this problem by using a recently developed genetically encoded red cAMP indicator, R-FlincA (ex = 587 nm) [34] . To determine if blue, green or UV radiation elicits an OPN3-dependent change in baseline cAMP levels, we used MNT-1 cells (with already low endogenous levels of OPN3 (Fig 3B) ) to express R-FlincA together with either OPN3-cYFP or YFP. We monitored R-FlincA fluorescence emission before, during, and after stimulation with 200 mW/cm 2 of blue, green or UV radiation (Supp. Fig. 6 ). We did not measure any light-induced or OPN3-dependent changes in cAMP levels, suggesting that the amount of UVR, blue, or green light applied does not modulate OPN3 activity. This would suggest that OPN3 is more likely to have full or partial constitutive activity. The constitutive activity of OPN3 might require conformational changes induced through direct or indirect interaction with MC1R. In fact, MC1R has unusually high partial constitutive activity, which is responsible for the baseline pigmentation in our skin and hair. The constitutive activity of OPN3, coupled to Gi, could be responsible for regulating both baseline cellular cAMP levels in the absence of MC1R agonists and cAMP levels upon MC1R activation.
Our colocalization ( Fig. 6 ) and co-immunoprecipitation ( Fig. 7) data indicate that OPN3 and MC1R reside in the same microdomains where they form a molecular complex. The presence of both OPN3 and MC1R in the same microdomains could explain the specific OPN3-mediated regulation of MC1R, but not of EP2 receptor signaling (Fig. 6) . The microdomain localization might allow OPN3 to become activated by binding to MC1R directly or via other proteins in the complex. Alternatively, the microdomain might contain the specific adenylyl cyclase that is activated by MC1R and inhibited by OPN3, or a particular phosphodiesterase that could be modulated by OPN3. In all these scenarios, OPN3 would not be able to modulate signaling via cAMP evoked by Gs-coupled receptors that are not localized to the same microdomains, like EP2 receptors. Heteromeric receptors have been described for other GPCRs and have been shown to have altered ligand binding, signaling, and internalization properties compared to the individual GPCRs [37, 38] . For example, in the brain, the melanocortin 3 receptor (MC3R), of the same melanocortin family as MC1R, and the ghrelin receptor (GHSR) form heteromers with altered melanocortin-and ghrelin-induced intracellular responses to regulate energy metabolism [46, 47] . Interestingly, OPN3 was initially identified in deep regions of the brain (hence the initial name "encephalopsin") [21] including the hypothalamus, where MC3R is also expressed [48] [49] [50] . This raises the intriguing question of whether OPN3 functions in the brain similar to how it does in melanocytes: could OPN3 interact and negatively regulate the function of other melanocortin receptors like MC3R? OPN3 is not the only opsin that functions as part of a dimeric complex; a functional homomeric complex has also been reported for rhodopsin (OPN2) and cone opsin (OPN1) [40] . These complexes are mediated by residues within the fifth transmembrane domain of human red and green opsins [39] , and by transmembrane domain one and helix eight for rhodopsin dimerization [40] . Whether OPN3 and MC1R directly interact through domain coupling or are part of a larger complex was beyond the scope of our study, but will be determined by future studies.
Our immunostaining results of both expressed and endogenous OPN3 and MC1R show that the two receptors colocalize at the plasma membrane as well as in intracellular compartments. Because recent studies showed that activated GPCRs are internalized and could continue to signal in endosomal compartments [51] , it is intriguing to hypothesize that MC1R and OPN3 continue to signal even when they are no longer at the plasma membrane. We wondered if the colocalization of OPN3 and MC1R in melanocytes depends on the activation state of MC1R. We compared the localization of OPN3 and MC1R in growth media not containing MSH and 1, 3 or 6 h after MSH stimulation (Supp. Fig. 7) . We found that MSH-mediated activation of MC1R did not cause a significant shift in the fraction of MC1R at the plasma membrane vs. intracellular organelles and, implicitly, did not alter the fraction of MC1R colocalized with OPN3, suggesting that both active and inactive forms of MC1R are associated with OPN3.
The findings presented here expand our understanding of OPN3 function and its role as an extra ocular opsin in human skin. We have uncovered a novel light-independent function of OPN3 in regulating melanin levels in human melanocytes. Taking into consideration that retinoic acid, a derivative of vitamin A, is widely used in skin treatments such as hyperpigmentation [52] [53] [54] and that OPN3 can bind retinal, OPN3 could yield a novel therapeutic target for skin pigmentation disorders such as melasma, and the OPN3-MC1R complex may reveal novel molecular mechanisms for opsin function and for regulating melanin production in melanocytes.
Materials and Methods
Cell culture and transfection. All cell culture reagents were purchased from ThermoFisher Scientific, unless otherwise stated.
HeLa cells, used for immunostaining and biochemical analyses of expressed tagged OPN3 and MC1R, were maintained at 37ºC and 5% CO2 in DMEM supplemented with 5% FBS and 100 units/ml penicillin/streptomycin and transiently transfected using Lipofectamine 2000 according to manufacturer's recommendations.
HEK293-GnTlcells, used for expression and purification of OPN3 variants and OPN2 (as a control) for
UV-visible spectroscopy, were maintained under standard conditions in DMEM supplemented with 10% FBS and 100 units/ml penicillin/streptomycin and transfected using calcium phosphate precipitation, as previously described [55] .
We used three types of melanocytes: Immunofluorescence. Cells seeded on glass coverslips were fixed with 4% paraformaldehyde at room temperature for 10 min, incubated with blocking solution [0.2% saponin, 0.1% BSA, 0.02% sodium azide] for 1 h, followed by overnight incubation with primary antibodies (1:200). For visualization, fluorescently labeled secondary antibodies (Life Technologies) (1:1000) were used. Confocal images were acquired using an Olympus FV3000 confocal microscope and analyzed using Image J software. The Pearson correlation coefficient (PCC) was calculated for each cell, as previously described [56] . Two proteins were considered significantly colocalized if the overlap was higher than 50% and not colocalized if was lower than 10% [57] . As a positive control for the colocalization analysis we calculated PCC for two wellcharacterized lysosomal proteins, TPC2 and LAMP1, expressed in HeLa cells, which showed ~50% overlap (Supp. Fig. 8 ). relative melanin content was calculated as the ratio of cellular melanin concentration for each experimental condition to control.
Ca
UV-visible spectroscopy. HEK293-GnTlcells plated on 100 mm culture dishes were transfected, using calcium phosphate precipitation, with OPN3ΔC-c1D4 or OPN3(K299G)ΔC-c1D4 (the ΔC truncation of amino acids 315-402 at the C-terminus increased protein yield). After three days, cells were harvested, centrifuged at 3,500 rpm for 20 min and re-suspended in PBS. All subsequent steps were performed in the dark. Cells were treated with 4.8 mM all-trans or 11-cis retinal at 4°C for 30 min, lysed with 1% n-Dodecyl-β-D-maltoside (DDM, Sigma Aldrich) at 4°C for 1 h, then centrifuged at 3,500 rpm for 20 min.
The supernatant containing the solubilized protein was incubated with pre-conjugated 1D4 antibody-Sepharose beads at 4°C for 2 h, then run through a disposable plastic column (ThermoFisher Scientific) and washed with 0.1% DDM. Proteins were eluted with 0.4 mM 1D4 peptide solution at 4°C. Absorbance spectra were measured on a Cary 50-UV visible spectrometer between 200 and 800 nm as previously described [55] . To test the presence of a Schiff-base bond between chromophore and the K299 residue of OPN3, 0.8% SDS and 80 µM NH2OH were added to create retinal oxime, which absorbs maximally at
Statistical analysis. For each tested condition, several replicate experiments were performed and results were averaged. All data are given as means ± SEM. Statistical differences among the experimental groups were analyzed by two-sided Student t test when comparing two experimental groups.
Significance was defined as *p < 0.05 and **p < 0.01. A. Two-dimensional model of human OPN3 (hOPN3). hOPN3, similar to rhodopsin, has 7 predicted transmembrane domains followed by a short intracellular helix (purple cylinders) and a unique Cterminus (amino acids 340-402, green) containing the epitope for the anti-OPN3 antibodies (blue outline) [58] . Each circle represents one amino acid. The conserved lysine K299 (red) is involved in retinal binding, which forms a Schiff base with counterion D117 (black). In melanocytes, αMSH binds to and activates the Gαs-coupled MC1R, leading to stimulation of adenylyl cyclase (AC) and a transient increase in cAMP levels, which, through a series of molecular steps, leads to activation and upregulation of the microphthalmia transcription factor (MITF). MITF controls the expression of tyrosinase (TYR), the main melanogenic enzyme; higher MITF levels will result in more TYR that will generate a higher amount of melanin. Our data suggest that OPN3, via Gαi activation, reduces the amount of cAMP generated by MC1R activation, causing decreased transcription of MITF and, in consequence, of TYR. OPN3 and MC1R form a complex and OPN3 may additionally alter the function of MC1R by enhancing its internalization and lowering the number of receptors available to bind αMSH at the plasma membrane.
B. OPN3 mRNA levels in

